QPEX BIOPHARMA, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2018-10-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.qpexbio.com
A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06547554
- Locations
- 🇺🇸
Minneapolis Clinic, Minneapolis, Minnesota, United States
PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT06157242
P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT06079775
- Locations
- 🇦🇺
CMAX, Adelaide, South Australia, Australia
Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects
- First Posted Date
- 2021-10-11
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT05072444
- Locations
- 🇺🇸
Altasciences, Cypress, California, United States
SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT04808414
- Locations
- 🇺🇸
Altasciences, Cypress, California, United States
Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT04578873
- Locations
- 🇺🇸
Altasciences, Cypress, California, United States
🇦🇺CMAX, Adelaide, South Australia, Australia
P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV
- First Posted Date
- 2020-05-08
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 82
- Registration Number
- NCT04380207
- Locations
- 🇺🇸
Altasciences, Cypress, California, United States
🇦🇺CMAX, Adelaide, South Australia, Australia
Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Qpex Biopharma, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT03939429
- Locations
- 🇦🇺
CMAX, Adelaide, South Australia, Australia
© Copyright 2024. All Rights Reserved by MedPath